Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis

Update Il y a 4 ans
Reference: NCT02015520

Woman and Man

Extract

The primary purpose of this study is to identify an appropriate dose of study medication.


Inclusion criteria

  • Rheumatoid Arthritis